Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-08-31 4:01 pm Purchase |
2023-08-21 | 13G | Arhaus, Inc. ARHS |
Citadel Advisors LLC | 2,887,707 5.400% |
2,887,707 (New Position) |
Filing History |
| 2023-08-21 4:07 pm Purchase |
2023-08-11 | 13G | Benitec Biopharma Inc. BNTC |
Citadel Advisors LLC | 180,030 6.900% |
180,030 (New Position) |
Filing History |
| 2023-08-11 4:01 pm Purchase |
2023-08-01 | 13G | Expensify, Inc. EXFY |
Citadel Advisors LLC | 2,711,663 4.000% |
2,711,663 (New Position) |
Filing History |
| 2023-07-27 4:01 pm Purchase |
2023-07-17 | 13G | Semper Paratus Acquisition Corporation LGST |
Citadel Advisors LLC | 933,454 5.900% |
933,454 (New Position) |
Filing History |
| 2023-07-10 4:01 pm Purchase |
2023-06-29 | 13G | Janux Therapeutics, Inc. JANX |
Citadel Advisors LLC | 2,126,135 5.100% |
2,126,135 (New Position) |
Filing History |
| 2023-07-03 4:02 pm Purchase |
2023-06-23 | 13G | Nektar Therapeutics NKTR |
Citadel Advisors LLC | 648,650 5.100% |
648,650 (New Position) |
Filing History |
| 2023-07-03 4:01 pm Purchase |
2023-06-21 | 13G | Clene Inc. CLNN |
Citadel Advisors LLC | 381,220 5.700% |
381,220 (New Position) |
Filing History |
| 2023-06-12 5:23 pm Purchase |
2023-05-31 | 13G | Lyra Therapeutics, Inc. LYRA |
Citadel Advisors LLC | 57,931 5.900% |
57,931 (New Position) |
Filing History |
| 2023-06-09 4:28 pm Purchase |
2023-05-30 | 13G | Inflection Point Acquisition Corp. II IPXXU |
Citadel Advisors LLC | 1,500,608 6.000% |
1,500,608 (New Position) |
Filing History |
| 2023-06-05 4:25 pm Purchase |
2023-05-25 | 13G | Icosavax, Inc. ICVX |
Citadel Advisors LLC | 2,189,469 5.300% |
2,189,469 (New Position) |
Filing History |
| 2023-05-19 4:06 pm Purchase |
2023-05-09 | 13G | Acelyrin, Inc. SLRN |
Citadel Advisors LLC | 5,963,800 6.100% |
5,963,800 (New Position) |
Filing History |
| 2023-05-19 4:05 pm Purchase |
2023-05-09 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Citadel Advisors LLC | 2,259,741 4.900% |
875,242 (+63.22%) |
Filing History |
| 2023-05-19 4:04 pm Purchase |
2023-05-09 | 13G | Alchemy Investments Acquisition Corp 1 ALCYU |
Citadel Advisors LLC | 663,323 5.500% |
663,323 (New Position) |
Filing History |
| 2023-05-19 09:15 am Purchase |
2023-05-18 | 13G | Coherus BioSciences, Inc. CHRS |
Citadel Advisors LLC | 5,815,074 6.200% |
5,815,074 (New Position) |
Filing History |
| 2023-05-15 4:47 pm Purchase |
2023-05-03 | 13G | Magenta Therapeutics, Inc. MGTA |
Citadel Advisors LLC | 4,087,110 6.700% |
4,087,110 (New Position) |
Filing History |
| 2023-05-01 4:49 pm Purchase |
2023-04-19 | 13G | 2seventy bio, Inc. TSVT |
Citadel Advisors LLC | 2,591,606 5.200% |
2,591,606 (New Position) |
Filing History |
| 2023-04-03 4:55 pm Purchase |
2023-03-23 | 13G | Design Therapeutics, Inc. DSGN |
Citadel Advisors LLC | 2,871,267 5.100% |
203,037 (+7.61%) |
Filing History |
| 2023-03-14 09:15 am Purchase |
2023-03-13 | 13G | Western Alliance Bancorporation WAL |
Citadel Advisors LLC | 5,935,538 5.400% |
5,935,538 (New Position) |
Filing History |
| 2023-03-06 4:11 pm Purchase |
2023-02-23 | 13G | Enliven Therapeutics, Inc. ELVN |
Citadel Advisors LLC | 2,298,756 5.600% |
2,298,756 (New Position) |
Filing History |
| 2023-02-27 4:02 pm Purchase |
2023-02-16 | 13G | Annexon, Inc. ANNX |
Citadel Advisors LLC | 2,500,307 5.200% |
1,018,285 (+68.71%) |
Filing History |